Literature DB >> 26773039

B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel.

Jonathan V Almaden1, Yi C Liu2, Edward Yang3, Dennis C Otero3, Harry Birnbaum4, Jeremy Davis-Turak1, Masataka Asagiri5, Michael David3, Ananda W Goldrath3, Alexander Hoffmann2.   

Abstract

Targeted deletion of BAFF causes severe deficiency of splenic B cells. BAFF-R is commonly thought to signal to nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB)-inducing kinase dependent noncanonical NF-κB RelB. However, RelB-deficient mice have normal B-cell numbers. Recent studies showed that BAFF also signals to the canonical NF-κB pathway, and we found that both RelB and cRel are persistently activated, suggesting BAFF signaling coordinates both pathways to ensure robust B-cell development. Indeed, we report now that combined loss of these 2 NF-κB family members leads to impaired BAFF-mediated survival and development in vitro. Although single deletion of RelB and cRel was dispensable for normal B-cell development, double knockout mice displayed an early B-cell developmental blockade and decreased mature B cells. Despite disorganized splenic architecture in Relb(-/-)cRel(-/-) mice, generation of mixed-mouse chimeras established the developmental phenotype to be B-cell intrinsic. Together, our results indicate that BAFF signals coordinate both RelB and cRel activities to ensure survival during peripheral B-cell maturation.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26773039      PMCID: PMC4786837          DOI: 10.1182/blood-2014-10-606988

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  71 in total

1.  Regulation of B cell activating factor (BAFF) receptor expression by NF-ΚB signaling in rheumatoid arthritis B cells.

Authors:  Yun Ju Woo; Bo Young Yoon; Joo Yeon Jhun; Hye Jwa Oh; Se Won Min; Mi La Cho; Sung Hwan Park; Ho Youn Kim; Jun Ki Min
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

Review 2.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.

Authors:  Cole Trapnell; Adam Roberts; Loyal Goff; Geo Pertea; Daehwan Kim; David R Kelley; Harold Pimentel; Steven L Salzberg; John L Rinn; Lior Pachter
Journal:  Nat Protoc       Date:  2012-03-01       Impact factor: 13.491

4.  Genetic CD21 deficiency is associated with hypogammaglobulinemia.

Authors:  Jens Thiel; Lucas Kimmig; Ulrich Salzer; Magdalena Grudzien; Dirk Lebrecht; Tina Hagena; Ruth Draeger; Nadine Voelxen; Nadine Völxen; Astrid Bergbreiter; Stephanie Jennings; Sylvia Gutenberger; Annette Aichem; Harald Illges; Jonathan P Hannan; Anne-Kathrin Kienzler; Marta Rizzi; Hermann Eibel; Hans-Hartmut Peter; Klaus Warnatz; Bodo Grimbacher; Jörg-Andres Rump; Michael Schlesier
Journal:  J Allergy Clin Immunol       Date:  2011-10-27       Impact factor: 10.793

5.  BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling.

Authors:  Sarah L Rowland; Katelyn F Leahy; Regina Halverson; Raul M Torres; Roberta Pelanda
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

6.  Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.

Authors:  Julia Jellusova; Ana V Miletic; Matthew H Cato; Wai-Wai Lin; Yinling Hu; Gail A Bishop; Mark J Shlomchik; Robert C Rickert
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

7.  IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner.

Authors:  Bryce N Alves; Rachel Tsui; Jonathan Almaden; Maxim N Shokhirev; Jeremy Davis-Turak; Jessica Fujimoto; Harry Birnbaum; Julia Ponomarenko; Alexander Hoffmann
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

8.  Combined immune deficiency in a patient with a novel NFKB2 mutation.

Authors:  Andrew W Lindsley; Yaping Qian; C Alexander Valencia; Kara Shah; Kejian Zhang; Amal Assa'ad
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

9.  Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency.

Authors:  Karin Chen; Emily M Coonrod; Attila Kumánovics; Zechariah F Franks; Jacob D Durtschi; Rebecca L Margraf; Wilfred Wu; Nahla M Heikal; Nancy H Augustine; Perry G Ridge; Harry R Hill; Lynn B Jorde; Andrew S Weyrich; Guy A Zimmerman; Adi V Gundlapalli; John F Bohnsack; Karl V Voelkerding
Journal:  Am J Hum Genet       Date:  2013-10-17       Impact factor: 11.025

10.  Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways.

Authors:  Vincent F-S Shih; Jeremy Davis-Turak; Monica Macal; Jenny Q Huang; Julia Ponomarenko; Jeffrey D Kearns; Tony Yu; Riku Fagerlund; Masataka Asagiri; Elina I Zuniga; Alexander Hoffmann
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606

View more
  16 in total

1.  Iterative Modeling Reveals Evidence of Sequential Transcriptional Control Mechanisms.

Authors:  Christine S Cheng; Marcelo S Behar; Gajendra W Suryawanshi; Kristyn E Feldman; Roberto Spreafico; Alexander Hoffmann
Journal:  Cell Syst       Date:  2017-02-22       Impact factor: 10.304

2.  LSD1 Cooperates with Noncanonical NF-κB Signaling to Regulate Marginal Zone B Cell Development.

Authors:  Robert R Haines; Christopher D Scharer; Jenna L Lobby; Jeremy M Boss
Journal:  J Immunol       Date:  2019-09-06       Impact factor: 5.422

3.  NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells.

Authors:  Yorleny Vicioso; Derek P Wong; Nand K Roy; Nayanika Das; Keman Zhang; Parameswaran Ramakrishnan; Reshmi Parameswaran
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

4.  Regulation of Marginal Zone B-Cell Differentiation by MicroRNA-146a.

Authors:  Jennifer K King; Nolan M Ung; May H Paing; Jorge R Contreras; Michael O Alberti; Thilini R Fernando; Kelvin Zhang; Matteo Pellegrini; Dinesh S Rao
Journal:  Front Immunol       Date:  2017-01-16       Impact factor: 7.561

5.  Differential requirements for the canonical NF-κB transcription factors c-REL and RELA during the generation and activation of mature B cells.

Authors:  Maja Milanovic; Nicole Heise; Nilushi S De Silva; Michael M Anderson; Kathryn Silva; Amanda Carette; Fabiano Orelli; Govind Bhagat; Ulf Klein
Journal:  Immunol Cell Biol       Date:  2016-09-21       Impact factor: 5.126

6.  SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.

Authors:  Cody Paiva; Taylor A Rowland; Bhargava Sreekantham; Claire Godbersen; Scott R Best; Prabhjot Kaur; Marc M Loriaux; Stephen E F Spurgeon; Olga V Danilova; Alexey V Danilov
Journal:  Haematologica       Date:  2017-08-24       Impact factor: 9.941

Review 7.  Migration and Adhesion of B-Lymphocytes to Specific Microenvironments in Mantle Cell Lymphoma: Interplay between Signaling Pathways and the Epigenetic Landscape.

Authors:  Laia Sadeghi; Anthony P Wright
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

Review 8.  ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies.

Authors:  Samantha Gokhale; Ping Xie
Journal:  Pharmaceutics       Date:  2021-06-20       Impact factor: 6.321

9.  Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.

Authors:  Maojun You; Liang Chen; Dawei Zhang; Peng Zhao; Zhu Chen; En-Qiang Qin; Yanan Gao; Mark M Davis; Pengyuan Yang
Journal:  Nat Cell Biol       Date:  2021-06-09       Impact factor: 28.213

Review 10.  Role of the NFκB-signaling pathway in cancer.

Authors:  Longzheng Xia; Shiming Tan; Yujuan Zhou; Jingguan Lin; Heran Wang; Linda Oyang; Yutong Tian; Lu Liu; Min Su; Hui Wang; Deliang Cao; Qianjin Liao
Journal:  Onco Targets Ther       Date:  2018-04-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.